Gyroscope's lead investigational gene therapy, GT005, is currently being evaluated in Phase II clinical trials for the treatment of geographic atrophy (GA) ...
https://www.google.com/url?rct=j&sa=t&url=https://www.pharmiweb.com/press-release/2021-03-29/syncona-cornerstones-148-million-series-c-financing-in-gyroscope&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AFQjCNGn8H_m1jACWBQ52X5CciQBBT_vtw
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.